MedPath
TGA Approval

HADLIMA adalimumab 40 mg/0.4 mL solution for injection in PushTouch auto-injector (384975)

384975

HADLIMA adalimumab 40 mg/0.4 mL solution for injection in PushTouch auto-injector

Samsung Bioepis AU Pty Ltd

February 15, 2023

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01179-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-01180-1

Active Ingredients

Adalimumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.